[DIV28SUPER] NYTimes: Cocktail of Popular Drugs May Cloud Brain

Studies find that the cumulative use of drugs that are among dozens of common painkillers, antihistamines and psychiatric medications has been linked to cognitive impairment. http://nyti.ms/wySepL. (cumulative anticholinergic effects RWW)

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28SUPER] Fwd: [Inwomen] InWomen's Evite is Here

 

	The Women's and Children's International Group invites you to attend the 2012 International Women's Fifth Meeting and Conference Friday, June 8, 2012, 11:00 to 18:00 Palm Springs, California, USA Women, Substance Abuse, Context & Treatment: Global Issues In conjunction with the NIDA International Forum and the 74th Annual Scientific Meeting of the College on Problems of Drug Dependence (CPDD) and co-sponsored by NIDA, CPDD, the U.S. Department of Health and Human Services' Office on Women's Health, RTI International, Danya International, and Reckitt Benckiser Pharmaceuticals Inc. This conference will bring together expert researchers and clinical providers passionate about and committed to improving the lives of women and children. CO-CHAIRS Frances E. Ashe-Goins, Office on Women's Health, U.S. Department of Health   and Human Services Wendee Wechsberg, Substance Abuse Treatment Evaluation and Interventions,  RTI International PLENARY LUNCH SPEAKER Cora Lee Wetherington, United States, Women and Sex/Gender Differences, Research Coordinator, NIDA – Sex/Gender Differences in Drug Abuse & Implications for Gender-Focused Treatment SPEAKERS Trecia Wouldes, New Zealand – The early environments of children born to mothers who use methamphetamine: A comparison of two cultures Irma Kirtadze, Republic of Georgia – A formative study of drug-using women in Georgia: Setting the stage for an RCT Olga Toussova, Russia – HIV risks among women IDUs and bridging populations in St. Petersburg, Russia SPECIAL EVENTS Thema Bryant Davis, Poetess on and about women DISCUSSION TABLES WITH EXPERTS Your choice of two 45-minute sessions. Please indicate your choices on the registration page. 1.    Evidence-based women-centered treatment 2.    Women and co-occurring disorders 3.    Family issues: Infant attachment, childhood trauma 4.    Global issues related to health disparities 5.    Evidence-based, young women-focused preventions 6.    Perinatal substance abuse 7.    What structural interventions are working for women 8.    Gender-based, interpersonal violence and victimization WRAP-UP AND GENERAL MEETING Please join us in our mission to advance our field and expand global collaborations. Registration is $50 US ($25 for attendees from developing countries) Lunch is included. To register click here. For more information, contact Dr. Wendee Wechsberg, wmw@rti.org. If you would like know the mission and join the InWomen's network, please go to http://nivc.perpich.com and register online. Membership is free. Your registration will be activated within 48 hours, and you will be automatically added to a discussion list to receive alerts for upcoming meetings. You will also have access to the meeings minutes and group resources.
SPONSORED BY

 

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

[DIV28M] Invitation to Become a Member of the College on Problems of Drug Dependence

Subject: Invitation to Become a Member of the College on Problems of Drug Dependence (CPDD)

Dear Colleagues,

 

On behalf of the College on Problems of Drug Dependence (CPDD), I invite you and your students, trainees, and colleagues to become members of CPDD.  The College serves as an interface among governmental, industrial and academic communities maintaining liaisons with regulatory and research agencies as well as educational, treatment, and prevention facilities in the drug abuse field.

 

More information about CPDD and the benefits of becoming a member can be found in the attached letter.  Also, please visit our website at http://www.cpdd.vcu.edu/.  I ask that you please forward this message to your colleagues, students, trainees and fellows who might be interested in joining CPDD.

 

Best wishes,

 

Adam Leventhal

Member, CPDD Membership Committee

adam.leventhal@usc.edu

_____________________________ div28m@lists.apa.org
restricted to APA members list archive
twitter: @apadiv28

[DIV28M] Invitation to Become a Member of the College on Problems of Drug Dependence

Subject: Invitation to Become a Member of the College on Problems of Drug Dependence (CPDD)

Dear Colleagues,

 

On behalf of the College on Problems of Drug Dependence (CPDD), I invite you and your students, trainees, and colleagues to become members of CPDD.  The College serves as an interface among governmental, industrial and academic communities maintaining liaisons with regulatory and research agencies as well as educational, treatment, and prevention facilities in the drug abuse field.

 

More information about CPDD and the benefits of becoming a member can be found in the attached letter.  Also, please visit our website at http://www.cpdd.vcu.edu/.  I ask that you please forward this message to your colleagues, students, trainees and fellows who might be interested in joining CPDD.

 

Best wishes,

 

Adam Leventhal

Member, CPDD Membership Committee

adam.leventhal@usc.edu

_____________________________ div28m@lists.apa.org
restricted to APA members list archive
twitter: @apadiv28

[DIV28SUPER] Www.apacommunities.org (Jive is live!)

"...Div. 28 membership data has been imported into APA Communities. Members should now be able to log in to www.apacommunities.org with their MyAPA username and password and access the Div. 28 space. ..."

Be among the first to enjoy this extraordinary social networking environment.. Limited to APA members and noncommercial, this is a truly innovative effort by APA to enhance your professional life.. Enable collaborations, share documents, maintain profiles.. A very rich tool, a real benefit of membership.

Ronald Wood PhD

Div28 electronic communications officer

And a past president 

[DIV28SUPER] NIDA Neuroscience Update, February 14, 2012

NOT-OD-12-045 Request for Information (RFI): Input into the Scientific Strategic Plan for the proposed National Institute of Substance Use and Addiction Disorders

 

Release Date: February 8, 2012

Response Date:  May 11, 2012

 

Through a Request for Information (RFI) the NIH is soliciting input into the Scientific Strategic Plan for the proposed new Institute with the working name of the National Institute of Substance Use and Addiction Disorders. This new Institute would result from the proposed reorganization of substance use, abuse, and addiction-related research at the NIH.  For more details concerning the solicitation, please go to http://grants.nih.gov/grants/guide/notice-files/NOT-OD-12-045.html

 

Responders should note that the NIH is only seeking input on the scientific opportunities and public health needs that should be included in the Scientific Strategic Plan for the new Institute.  Input is sought on areas described in the RFI as well as any areas that NIH might consider.  For any of the areas identified in the RFI and any other specific areas you believe are worthy of consideration by NIH, please

 

(1)         identify the critical issues(s)

(2)         explain their effect(s) on the public, on scientists, or both; and

(3)         identify and explain which of the issues you identified are, in your opinion, the most important for NIH to address and why.

 

All comments must be submitted electronically to: http://grants.nih.gov/grants/guide/rfi_files/nih_nisuad/add.cfm

 

PAR-12-086 Cutting-Edge Basic Research Awards (CEBRA) (R21)

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to drug abuse and addiction and how to prevent and treat them. It supports research that is high-risk and potentially high-impact that is underrepresented or not included in NIDA's current portfolio. The proposed research should: (1) test a highly novel and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would have a substantial impact on current thinking; and/or (2) develop or adapt innovative techniques or methods for addiction research, or that have promising future applicability to drug abuse research.  Application due dates: August 20, 2012; December 20, 2012; August 20, 2013, December 20, 2013, August 20, 2014, and December 19, 2014 , by 5:00 PM local time of applicant organization.

 

 

Proposals Sought to Support Pain Management Education in Health Professional Schools
The NIH Pain Consortium is encouraging medical, dental, nursing and pharmacy schools to respond to a new funding opportunity to develop Centers of Excellence in Pain Education (CoEPEs). The National Institute on Drug Abuse is the lead Institute on this effort.  On December 30^th, 2011, a Request for Proposals (RFP) was released by Altarum Institute and Palladian Partners, an Altarum company, on behalf of the NIH Pain Consortium, to develop and disseminate pain management curriculum resources for health care professionals and to provide leadership for change in pain management education. The deadline to submit applications is March 5^th, 2012.  The RFP can be found at:  <http://www.altarum.org/project-highlights-pain-education>.

 

 

RFA-HD-12-211: Tools to Enhance Studies of Glial Cell Development, Aging, Disease and Repair (R21):

Discovery-based or high-risk applications that focus directly on tool development will be considered responsive to this announcement. Applicants can propose to develop tools or technologies for the study of any type of glial cell within the central or peripheral nervous systems. We are using the R21 grant mechanism that provides funding for 2 years at up to $275K direct costs total over the 2 year funding period. Applications are due by 29 March 2012.  http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-12-211.html

 

--------------

TO UNSUBSCRIBE: send email to listserv@list.nih.gov, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email

- You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309

[DIV28SUPER] Intent to Publish a Request for Applications for Centers of Excellence for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P50)

A Notice has been posted that may be interest to you: http://grants.nih.gov/grants/guide/notice-files/NOT-DA-12-007.html

Notice of Intent to Publish a Request for Applications for Centers of Excellence for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P50)

Notice Number: NOT-DA-12-007
Key Dates

Release Date: February 13, 2012
Estimated Publication Date of Announcement: Spring 2012
First Estimated Application Due Date: Fall 2012
Earliest Estimated Award Date: July 2013
Earliest Estimated Start Date: July 2013

Issued by

National Institute on Drug Abuse (NIDA)
National Cancer Institute (NCI)
National Institute of Environmental Health Sciences (NIEHS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The National Institute on Drug Abuse (NIDA), the National Cancer Institute (NCI), the National Institute of Environmental Health Sciences (NIEHS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Mental Health (NIMH), and the National Institute of Neurological Disorders and Stroke (NINDS), in conjunction with other IC partners, intends to publish a Funding Opportunity Announcement (FOA) to establish Centers for tobacco regulatory science to conduct programs of multidisciplinary research that will aid the development and evaluation of tobacco product regulations. The Centers program will conduct research that addresses research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP). Support for the Centers will come from funds provided to NIH through the FDA CTP to support tobacco regulatory science as per the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31. The NIH and the FDA have formed an interagency partnership to foster regulatory science. Within the framework of the Tobacco Control Act, the FDA and NIH share interest in supporting science that can assist the FDA in the development and evaluation of tobacco product regulations. Projects resulting from this FOA are expected to serve the FDA by generating relevant findings and data needed to inform the regulation of the manufacture, distribution, and marketing of tobacco products to protect public health. Consistent with the FDA CTP mission, this FOA seeks research centers that address such topics as: the diversity of tobacco products, reducing addiction, reducing toxicity and carcinogenicity, adverse health consequences, communications, marketing of tobacco products, and economics and policies. See the NIH Web site for additional information http://cancercontrol.cancer.gov/nih-fda

This Notice is provided to allow prospective applicants sufficient time to develop essential collaborations and plans prior to submitting an application in response to the published FOA.

The FOA is expected to be published in the NIH Guide for Grants and Contracts in Spring 2012 with an expected receipt date in Fall 2012.

The FOA will utilize the Specialized Center (P50) funding mechanism for research centers. NIH and FDA intend to make 8-10 research center awards, with a maximum of 5 years of funding; NIH and FDA intend to make one coordinating center award; the coordinating center mechanism is to be determined.

Research Initiative Details

Centers resulting from this FOA are expected to demonstrate research excellence and leadership to accelerate the pace of science that will guide FDA actions to reduce the public health toll from tobacco products in the United States. A Center application must propose a program of multidisciplinary research around a unifying or well-defined goal or targeted area of research that will aid the development and evaluation of tobacco product regulations. The research Center is required to have a minimum of three component research projects that are judged to have independent scientific merit and to contribute to the overall research theme of the center.

The goal of this FOA is to fund research relevant to FSPTCA. With the passage of FSPTCA in June 2009, the FDA has authority to regulate the manufacture, marketing, and distribution of tobacco products in order to protect public health. Although a vast and sound science base exists with regard to numerous areas related to the FSPTCA, new research will provide additional science for FDA to consider as it implements the FSPTCA. Research and pilot studies supported by this notice will be used to provide scientific evidence in seven areas as follows.

• Diversity of Tobacco Products - understanding the constituents, components, ingredients, additives, and design features; use behaviors; perceptions, attitudes and beliefs of conventional and new and emerging tobacco products
• Reducing Addiction - understanding dependence in relation to nicotine level; how reductions in nicotine affect use behaviors; other constituents and components beyond nicotine that affect addiction of combustible and non-combustible tobacco products
• Reducing Toxicity and Carcinogenicity - understanding how reductions in toxicity of tobacco products affect use behaviors and perceptions; what level of reduction in harmful and potentially harmful constituents result in decreased disease risk; what assays best compare toxicity between different tobacco products
• Adverse Health Consequences - understanding health risks of multiple tobacco types; what biomarkers of disease risk can be associated with measures of tobacco exposure; what novel biological and physiological markers are predictive of tobacco-related adverse health outcomes
• Communications - understanding how to effectively convey information regarding risks associated with tobacco product use and FDA's regulatory authority over tobacco products
• Marketing of Tobacco Products - understanding the impact of tobacco product marketing on use behaviors, perception, attitudes and beliefs
• Economics and Policies - estimating the economic impact of FDA regulatory actions; understanding the impact of FDA regulatory actions on tobacco use and on overall morbidity and mortality

APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.

Inquiries

Please direct all inquiries to:

Kay Wanke, PhD, MPH
Epidemiology Research Branch
Division of Epidemiology, Services and Prevention Research
National Institute on Drug Abuse
(301) 402-0036 (Direct)
(301) 443-6504 (Main)
(301) 443-2636 (Fax)
Email: kay.wanke@nih.gov

Stacey Vandor
Division of Cancer Control and Population Sciences
National Cancer Institute
(301) 594-6786 (Direct)
(301) 594-6776 (Main)
(301) 594-6787(Fax)
Email: Stacey.vandor@nih.gov

Srikanth S Nadadur, M.Sc., Ph.D.
Cellular, Organs and Systems Pathobiology Branch
Division of Extramural Research and Training
National Institute of Environmental Health Sciences
(919) 541-5327 (Direct)
(919) 541-1919 (Main)
(919) 541-0462 (Fax)
Email: nadadurs@niehs.nih.gov

Caroline Signore, MD, MPH
Pregnancy and Perinatology Branch
Eunice Kennedy Shriver National Institute of
Child Health and Human Development
(301) 496-5577 (Direct)
(301) 496-5575 (Main)
(301) 496-3790 (Fax)
Email: signorec@mail.nih.gov

Denise Juliano-Bult, M.S.W.
Division of Services and Intervention Research
National Institute of Mental Health
(301) 443-1638 (Direct)
(301) 443-4045 (Fax)
Email: djuliano@mail.nih.gov

Randall R. Stewart, Ph.D.
Division of Extramural Research
National Institute of Neurological Disorders and Stroke
(301) 496-6460 (Direct)
(301) 496-1917 (Main)
(301) 402-1501 (Fax)
E-mail: stewartr@ninds.nih.gov

 

Regards,

Allison

 

******************************************************************

Allison C. Hoffman, Ph.D., Office of Science
Center for Tobacco Products/FDA
301.796.9203
CTP Call Center: 1.877.CTP.1373

www.fda.gov/tobaccoproducts

 

******************************************************************

 

 

[DIV28SUPER]

http://gaiarestaurante.com/images/Coty.htm

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28SUPER] Request for Information (RFI): Input into the Scientific Strategic Plan for the proposed National Institute of Substance Use and Addiction Disorders

The following message is being sent on behalf of David Shurtleff, NIDA Deputy Director:

Request for Information (RFI): Input into the Scientific Strategic Plan for the proposed National Institute of Substance Use and Addiction Disorders

Release Date: February 8, 2012
Response Date: May 11, 2012

Through a Request for Information (RFI) the NIH is soliciting input into the Scientific Strategic Plan for the proposed new Institute with the working name of the National Institute of Substance Use and Addiction Disorders. This new Institute would result from the proposed reorganization of substance use, abuse, and addiction-related research at the NIH. For more details concerning the solicitation, please go to http://grants.nih.gov/grants/guide/notice-files/NOT-OD-12-045.html

Responders should note that the NIH is only seeking input on the scientific opportunities and public health needs that should be included in the Scientific Strategic Plan for the new Institute. Input is sought on areas described in the RFI as well as any areas that NIH might consider. For any of the areas identified in the RFI and any other specific areas you believe are worthy of consideration by NIH, please

(1) identify the critical issues(s)
(2) explain their effect(s) on the public, on scientists, or both; and
(3) identify and explain which of the issues you identified are, in your opinion, the most important for NIH to address and why.

All comments must be submitted electronically to: http://grants.nih.gov/grants/guide/rfi_files/nih_nisuad/add.cfm

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28SUPER] Request for Input into Strategic Plan for proposed National Institute of Substance Use and Addiction Disorders

NIH is seeking input on the scientific opportunities and public health needs that should be included in the Scientific Strategic Plan for the new institute.  See the official notice, released today, at:

http://grants.nih.gov/grants/guide/notice-files/NOT-OD-12-045.html

[DIV28SUPER] Div 28 award winners

Hi Division 28 members,

As with most years, we had a very strong field of nominees for the 2012 Div 28 awards.  Thanks to all who applied and I strongly encourage you to apply again next year if you did not win this year.  Congratulations for our winners:  

 

Ben Lewis - Dissertation Award

Warren Bickel - Med Associates Brady/Schuster Award

Adam Leventhal - Young Psychopharmacologist Award

 

Cheers,

Chana

Div 28 Awards Chair

 

--------------------------------

Chana K. Akins, Ph.D.

Professor

Department of Psychology

University of Kentucky

Lexington, KY 40506-0044

phone: (859)257-1103

fax: (859)323-1979

 

 

[DIV28SUPER] Fwd: 2012 APA LIWP Call for Applications

Sent from my iPhone

Begin forwarded message:

From: "Cooke, Keith" <kcooke@apa.org>
Date: February 6, 2012 9:31:10 AM EST
Subject: 2012 APA LIWP Call for Applications

Please consider sharing with your listservs.

 

Keith Cooke

APA Division Services Office

 

 

5th Annual Leadership Institute for Women in Psychology

July 30-August 1, 2012, Orlando, FL and March 14, 2013, Washington, DC

View the 2012 Call for Applications

Learn more about the APA Leadership Institute for Women in Psychology

 

 

Deadline to submit: March 12, 2012

 

Please note: the Academic and Academic Medicine application reflected an error in the 'Supporting Documents' section. A change has been made to reflect the appropriate requirement of one letter of recommendation from a person most familiar with your leadership aspirations and potential (preferably from a Dean or your Department Chair) which addresses how she or he envisions your leadership role(s) in the next two years.

 

The American Psychological Association Committee on Women in Psychology (CWP) announces its fifth annual Leadership Institute for Women in Psychology to be held on  Monday, July 30, Tuesday, July 31 and August 1, 2012 in Orlando, FL and March 2013 in Washington, DC.  This year we are accepting approximately 30 mid-career women psychologist who work full time in academic/academic medical settings, and approximately 30 mid-career women psychologists who work primarily in clinical or consulting settings. Mid-career women psychologists in leadership roles in integrated primary care settings in academic health centers, public, community or private sectors are encouraged to apply as well. This is a competitive process.  Please complete the application for the group with which you most clearly identify and meet the eligibility criteria discussed below.

 

The overall mission of the LIWP is to empower, prepare and support women psychologists as leaders to promote positive changes in institutional, organizational and practice settings as well as APA and State, Provincial, and Territorial Associations (SPTA) governance, and increase the diversity, number, and effectiveness of women psychologists as leaders. The program's mission supports APA's goal to advance psychology as a science and profession and as a means of promoting health, education and human welfare.

 

The APA Leadership Institute for Women in Psychology has several objectives:

 

1.       Ensure that mid-career and senior women in psychology have the knowledge and skills necessary to compete for leadership/senior management positions in academic, practice, and other professional settings as well as APA and SPTA governance.

 

2.       Enhance the number and effectiveness of women psychologists holding leadership positions in academic, practice, and other professional settings as well as APA and SPTA governance.

 

3.       Increase the diversity of women psychologists in academic, practice, and other leadership positions as well as APA and SPTA governance.

 

4.       Create networks of women psychologists in leadership/senior management positions in varied professional settings including APA and SPTA governance.

 

5.       Document the career movement, professional advancement as well as the perceived impact of the LIWP among participants.

 

 

Who Should Apply?

 

Mid-career (10-20 years post-doctoral degree) women psychologists who are APA members with demonstrated leadership experience, strengths and goals:

 

a)      holding either full-time, paid faculty appointments at the associate professor or clinical associate professor level or above in academic or academic medicine settings

 

Or

 

b)      working 20 or more hours per week primarily in clinical or consulting  settings. If you are in a clinical setting, you must be a licensed psychologist to apply to the LIWP.

 

Or

 

c)       if you are more than 20 years post-doctoral degree but view yourself as mid-career and not senior, provide careful justification for your application as a mid-career psychologist in academic, academic medical, clinical or consulting settings.          

 

Women of color, lesbian and bisexual women, transgender women, and women with disabilities are strongly encouraged to apply.

 

Program components

 

·         Highly interactive, skills-focused workshops with experts in the field.  The core curriculum includes:

·         Leadership Models

·         Mid-Career Management, Goal Setting and Planning

·         Negotiation Skills

·         Mentoring Networks, including gender and diversity issues

 

Previous Institutes and Web seminars during the year have also addressed:

 

·         Sustaining and Funding a Research Program

·         Fiscal, Program, and Personnel issues

·         Managing Work-Life Balance

·         Strategic Planning

·         Dealing with Difficult People

 

Individuals who participate will leave with clearly defined professional goals and identify next steps towards promotion and leadership positions.

 

Applications and supporting materials (CV or resume and one letter of recommendation) are due by 5:00 pm eastern time on Monday, March 12, 2012.  Applications submitted after the deadline or incomplete applications will not be considered. Please complete either the application for mid-career women in academic and academic medical settings or the application for mid-career women in clinical and consulting settings. The applications are not the same. You may also print out the completed application and: either fax it with accompanying documents to the Women's Programs Office at (202) 336-6117 or send an email with your name and the track to which you are applying in the subject line.

 

If selected, participants will be asked to pay a $600 fee, which covers registration, program materials, and food (breakfast, lunch and snacks). In addition, participants are expected to attend a follow-up leadership program in March 2013 at the APA headquarters in Washington, DC; and complete questionnaires on an annual basis regarding career advancement and leadership training needs. Participants are also invited to Web seminars on leadership issues throughout the year; and have access to a list serve for LIWP participants, faculty and staff.

 

Selections will be announced by Monday, May 9, 2012.

 

For additional information, please review frequently asked questions or contact Shari Miles-Cohen, PhD, Senior Director, Women's Programs Office.

1.       Via hard copy to the American Psychological Association, 750 First St., NE, Washington, DC 20002-4242

 

2.       Via phone at (202) 336-6044

 

3.       Via email to womensleadershipinstitute@apa.org.

 

The American Psychological Association Leadership Institute for Women in Psychology has been generously funded by APA Board of Directors, the APA Council of Representatives, the APA Women's Programs Office, the National Institutes of Health Office of Research on Women's Health, Psychologists in Independent Practice, the Society for the Psychological Study of Ethnic Minority Psychology, the Society for the Psychological Study of Gay, Lesbian, Bisexual Issues, the Society for the Psychology of Women, and the Women's Caucus of the APA Council of Representatives.

 

Kari Hill | Program Assistant, Women's Programs Office

Public Interest Directorate

American Psychological Association

750 First Street NE, Washington, DC 20002-4242

Tel: 202.336.6044 |  Fax: 202.336.6117

email: khill@apa.org | http://www.apa.org/pi/women/index.aspx

P Please consider the environment before printing this email

 

[DIV28SUPER] APA--ECP Travel Awards

A great opportunity for the division to support its ECPs through these
awards from APA!

The Committee on Early Career Psychologists is pleased to announce the
travel award program for early career members from all areas of
psychology (education, practice, public interest and science) to attend
the 2012 APA Annual Convention in Orlando, Florida, August 2-5, at the
Orange County Convention Center.

Twenty award recipients will receive $750 to be applied toward their
2012 APA convention expenses. The program is designed to encourage
attendance and increase representation of early career members at this
year's APA convention.

All early career APA members (within seven years receipt of their
doctorate) are encouraged to apply. Preference will be given to
applicants who are first-time attendees, or whose primary work is in
basic psychological science or those who will be presenting at the 2012
convention. The submission package must include the following
information:

1. Brief statement (maximum one page) about your interest in
attending the convention and how you will use this award to support your
attendance. Please highlight any significant achievements in your career
as well as any leadership positions you have held as an early career
psychologists (within APA, other related scholarly or professional
organizations such as state and local psychological associations) and
indicate how you believe you would benefit from attending the
convention. Also, please include in your statement if your primary work
is in basic psychological science, if the 2012 convention will be your
first APA convention and if you will be receiving other funding to help
cover your expenses.

2. If you are presenting at the 2012 APA convention, please
include an abstract of your presentation along with the title and the
names of co-presenters. Please note that you do not need to be a
presenter to be eligible for this travel award.

3. Include your Curriculum Vitae (the year you were awarded a
doctorate in psychology should be clearly stated).

Electronic submission instructions: Please submit all materials in a
single Word document. Put your name and the name of the award in the
subject line (e.g. Jane Smith, Early Career Travel Award).

The deadline for submission of materials is March 23, 2012, midnight
(EST). Email or fax all materials to Sonja Wiggins (swiggins@ap.org);
fax # 202-216-7628. Award winners will be notified in April 2012 and
will be acknowledged during the Early Career Social Hour sponsored by
the Committee on Early Career Psychologists at the APA convention on
Friday, August 3, 2012 at 6PM.

----- End forwarded message -----

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28SUPER] Convention Travel Awards for Early Career Professionals

American Psychological Association

2012 APA Convention Travel Awards

for Early Career Professionals

 

The Committee on Early Career Psychologists is pleased to announce the travel award program for early career members from all areas of psychology (education, practice, public interest and science) to attend the 2012 APA Annual Convention in Orlando, Florida, August 2-5, at the Orange County Convention Center.

 

Twenty award recipients will receive $750 to be applied toward their 2012 APA convention expenses.  The program is designed to encourage attendance and increase representation of early career members at this year's APA convention.

 

All early career APA members (within seven years receipt of their doctorate) are encouraged to apply. Preference will be given to applicants who are first-time attendees, or whose primary work is in basic psychological science or those who will be presenting at the 2012 convention. The submission package must include the following information:

 

1.      Brief statement (maximum one page) about your interest in attending the convention and how you will use this award to support your attendance. Please highlight any significant achievements in your career as well as any leadership positions you have held as an early career psychologists (within APA, other related scholarly or professional organizations such as state and local psychological associations) and indicate how you believe you would benefit from attending the convention.  Also, please include in your statement if your primary work is in basic psychological science, if the 2012 convention will be your first APA convention and if you will be receiving other funding to help cover your expenses.

 

2.      If you are presenting at the 2012 APA convention, please include an abstract of your presentation along with the title and the names of co-presenters. Please note that you do not need to be a presenter to be eligible for this travel award.

 

3.      Include your Curriculum Vitae (the year you were awarded a doctorate in psychology should be clearly stated).

 

Electronic submission instructions:  Please submit all materials in a single Word document.  Put your name and the name of the award in the subject line (e.g. Jane Smith, Early Career Travel Award).

 

The deadline for submission of materials is March 23, 2012, midnight (EST). Email or fax all materials to Sonja Wiggins (swiggins@ap.org); fax # 202-216-7628.  Award winners will be notified in April 2012 and will be acknowledged during the Early Career Social Hour sponsored by the Committee on Early Career Psychologists at the APA convention on Friday, August 3, 2012 at 6PM.

 

Revised: January 20, 2012

 

 

 

 

 

--
Kelly Dunn, Ph.D.
NIDA Postdoctoral Fellow
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
CLH Phone: (410) 550-5370
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

[DIV28SUPER] Cellular Biology of Addiction Course, Barcelona, Spain July 18-25, 2012; Application deadline March 15, 2012

The National Institute on Drug Abuse is pleased to support the Summer Course, "Cellular Biology of Addiction in Barcelona, Spain, July 19-25, 2012  being sponsored by the Universitat Pompeu Fabra in partnership with Cold Sping Harbor Laboratory (CSHL).   We hope you will apply.  The deadline for applications is March 15, 2012.  To apply go to http://www.suportserveis.cat/CSHLSummerCourse/  Please tell interested person about the course.

 

Index Pre-Registration General Information Venue Visa and Travel Accommodation and board
	SUMMER COURSE "CELLULAR BIOLOGY OF ADDICTION" Partnered with the CSHL July 19 - July 25, 2012 Application Deadline: March 15, 2012 Instructors: Rafael Maldonado, Universitat Pompeu Fabra Brigitte L. Kieffer, CERBM/University of Strasbourg Chris Evans, University of California, Los Angeles, USA Antonello Bonci, National Institute on Drug Abuse-NIDA, Baltimore, USA The primary objective of the workshop is to provide an intense discussion of the fundamentals, state-of-the-art advances and major gaps in the cell and molecular biology of drug addiction. Targeted to both new and experienced investigators, the workshop will combine formal presentations and informal discussions to convey the merits and excitement of cellular and molecular approaches to drug addiction research. The workshop will stress the significance of this approach not only to the most costly neuropsychiatric disorder, addiction, but its applicability to learning, memory, neurochemical correlates of reward, perception and other disciplines of neuroscience. Research on the molecular and cellular changes that occur in response to drugs is critical for clarifying whether adaptive processes are diverse for each stage of addiction and for each drug of abuse. With the advent of genomics and proteomics, an extraordinary opportunity now exists to develop comprehensive models of neuroadaptative processes fundamental to addiction, craving, and relapse to drug use. The workshop will provide attendees with a spectrum of disciplines that can contribute to developing comprehensive models of each stage of drug addiction. The following disciplines will be presented: 1.Overview of addiction. 2. Neuroadaptation to drugs of abuse. 3. Association between drug-induced neuroadaptation and behavioral manifestations 4. Genotype/susceptibility to drug addiction or drug response 5. Tolerance, sensitization and adaptation at the cellular level 6. New receptor targets. 7. Drug discovery and development to treat drug abuse: how can cell biology contribute?   This workshop will provide an integrated view of current and novel research on neuroadaptive responses to addiction, foster discussion on collaboration and integration and provide critical information needed to construct a model of addiction as a disease and novel molecular targets for biological treatments. Beyond the plane of scientific endeavour, such information is vital for formulating public policy and for enlightening the public on the neurobiological consequences of drug use and addiction. The proposed workshop will generate intense interest, open conduits for collaborations and novel routes to investigating the neurobiology of addiction. The workshop makes particular efforts to include a diverse group of participants, being particularly mindful of the inclusion of women and a good balance of European and North American scientists. Confirmed speakers David Belin (University of Poitiers, Poitiers, France) Antonello Bonci (National Institute on Drug Abuse, Baltimore, USA) Carmen Cavada (Universidad Autónoma de Madrid, Madrid, Spain) Charles Chavkin (University of Washington, Seattle, USA) Chris Evans (University of California, Los Angeles, USA) David Goldman (Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, Rockville, USA) Markus Heilig (NIAA, Rockville, USA and Faculty of Health Sciences, Linköping University, Linköping, Sweden) Istvan Katona (Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary) Brigitte L. Kieffer (CERBM and University of Strasburg, Illkirch, France) George F. Koob and Barbara Mason (Scripps Institute, La Jolla, USA) Mary-Jean Kreek (Rockeffeler University, New York, USA) Evgeny Krupitsky (AV Valdman Institute of Pharmacology, St. Petersburg State I. P.Pavlov Medical University, St. Petersburg, Russia) Angus C. Nairn (Yale University, New Haven, USA) Richard Palmiter (Howard Hughes Medical Institute and Department of Biochemistry, University of Washington, Seattle, USA) Marina Picciotto (Yale University, New Haven, USA) Jonathan Pollock (National Institute on Drug Abuse, Bethesda, USA) Rafael Maldonado (Neurophar, University Pompeu Fabra, Barcelona, Spain) Vladimir de Semir (Universitat Pompeu Fabra, Barcelona, Spain) Rainer Spanagel (Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany) Kari Stefansson (DeCode Genetics, Reykjavik, Iceland) Pier Vincenzo Piazza (NeuroCenter François Magendie, INSERM, Bordeaux, France) Nora D. Volkow (National Institute on Drug Abuse, Bethesda, USA) Taco de Vries (VU University Medical Center, Amsterdam, The Netherlands) Ilana Witten (Stanford University, Stanford, USA) Andreas Zimmer (University of Bonn, Germany) The course will be held at the PRBB (Barcelona Biomedical Research Park) excellently located at Barcelona's seafront. The course is supported with funds provided by the National Institute of Drug Abuse  and the Federation of European Neuroscience Societies . Scholarships funds are available for partial support of tuition, room and board on a merit basis. Partial support from the Spanish (MINECO) and the Catalan (AGAUR) Governments is also acknowledged. Cost (including board and lodging): 1,500 € (This cost will be reduced by the scholarship program on an individual basis). Currency converter Click here for more information and way to register for the course http://www.suportserveis.cat/CSHLSummerCourse/
Welcome Course Information   Personal Area   User: Password: Remember password

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services

TO UNSUBSCRIBE: send email to listserv@list.nih.gov, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email

- You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309